Dishman Pharmaceuticals & Chemicals (Delisted) share news and announcements

BSE: 532526

Last traded ₹301.20 on 29 May 2017

Delisted on 8 Jan 2018.

Dishman Pharmaceuticals & Chemicals share news and announcements

747 announcements, routine notices left out, newest first. Page 5 of 15.

Jan 2016
- 30 Jan · Board meeting
  Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended 31st December, 2015. (opens in a new tab)
- 28 Jan · Business
  Vide letter dated January 28, 2016 regarding a press release titled "Dishman Netherlands awarded for its Corporate Social Responsibility". (opens in a new tab)
- 28 Jan · Business
  Press Release titled "Dishman Netherlands awarded for its Corporate Social Responsibility". (opens in a new tab)
- 13 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, .... (opens in a new tab)
Dec 2015
- 21 Dec · Updates
  Intimation of Analyst /Institutional Investors Meeting held Under SEBI (LODR) Regulation , 2015. (opens in a new tab)
- 19 Dec · Disclosure under Reg. 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
  Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (opens in a new tab)
- 7 Dec · Updates
  Company has appointed Dr. Himani Dhotre, most experience Chemist as CEO for its Bavla Plant. (opens in a new tab)
- 7 Dec · Chief Executive Officer (CEO) for Bavla Plant
  Company has appointed Dr. Himani Dhotre, most experience Chemist as CEO for its Bavla Plant. She has been working ....
- 2 Dec · Updates
  Details of the authorised persons for the purpose of determining the materiality of any event or transaction or information and for the purpose of making disclosure to Stock Exchange pursuant to Regulation 30(5) of the SEBI(Listing Obligation and Disclosure Requirements) Regulations, 2015. (opens in a new tab)
- 1 Dec
  Updates (opens in a new tab)
Nov 2015
- 30 Nov · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 27 Nov · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 17 Nov · News Verification
  Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to recent news item captioned "USFDA gives Warning Letter to Dishman due to Clovis issues." The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dishman Pharmaceuticals and Chemicals Limited has submitted their response. (opens in a new tab)
- 17 Nov · Clarifies on News item
  With reference to the news reported on moneycontrol on 17/11/2015 - "USFDA gives Warning Letter to Dishman due to Clovis issues", Dishman Pharmaceuticals and Chemicals Ltd has submitted .... (opens in a new tab)
- 17 Nov · News Verification
  Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited, with respect to recent news item captioned "USFDA gives Warning Letter to Dishman due to Clovis issues". In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
- 17 Nov · Legal
  Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Ltd with reference to the news reported on moneycontrol on 17/11/2015) - "USFDA gives Warning Letter ....
- 6 Nov · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 6 Nov · Disclosure
  Arpit J Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 5 Nov · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 3 Nov · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
Oct 2015
- 29 Oct · Limited Review Report for Sept 30, 2015
  Limited Review Report for the period ended September 30, 2015. (opens in a new tab)
- 29 Oct · Results
  Standalone & consolidated financial results for the period ended 30-Sep-2015. (opens in a new tab)
- 29 Oct · Results
  Financial Results for the period ended September 30, 2015. (opens in a new tab)
- 23 Oct · Meeting
  Proceedings of Annual General Meeting held on September 29, 2015. (opens in a new tab)
- 23 Oct · Meeting
  Proceedings of 32nd Annual General Meeting of the Company held on September 29, 2015. (opens in a new tab)
- 13 Oct · Shareholding Pattern for September 30, 2015
  Shareholding Pattern as on September 30, 2015. (opens in a new tab)
- 7 Oct · Board meeting
  Inter alia, to consider and take on record the Unaudited Financial Results (Provisional) of the Company for the quarter ended September 30, 2015. (opens in a new tab)
- 1 Oct · Disclosure of Voting Pattern - Clause 35A
  Details of voting results of the Annual General Meeting of the Company held on the September 29, 2015 along with Report of Scrutinizer pursuant to clause 35A of the Listing Agreement. (opens in a new tab)
- 1 Oct · Results
  Details of Voting results at the 32nd Annual General Meeting (AGM) of the Company held on September 29, 2015, under .... (opens in a new tab)
Sep 2015
- 30 Sep · Disclosure
  Arpit J Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 23 Sep · Updates
  Dishman has been awarded manufacture of SIRTURO (bedaquiline) API (opens in a new tab)
- 23 Sep · Business
  Dishman has been awarded manufacture of SIRTURO® (bedaquiline) API (opens in a new tab)
- 18 Sep · Meeting
  Minutes of the Extra Ordinary General Meeting (EGM) of the Company held on August 14, 2015. (opens in a new tab)
- 18 Sep · Meeting
  Minutes of Extra Ordinary General Meeting of the Company held on August 14, 2015. (opens in a new tab)
- 8 Sep · Meeting
  For the purpose of 32nd Annual General Meeting, the Company will provide the e-voting facility to its members in respect ....
- 8 Sep · Meeting
  For the purpose of 32nd Annual General Meeting, the Company will provide the e-voting facility to its members in respect of the businesses to be transacted at 32nd Annual General Meeting schedule to be held on September 29, 2015. Therefore, the Company has fixed September 22, 2015 as cut off date for the purpose of determining the members entitled to vote electronically. (opens in a new tab)
- 7 Sep · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
Aug 2015
- 31 Aug · Limited Review Report for June 30, 2015
  Limited Review Report for the period ended June 30, 2015. (opens in a new tab)
- 31 Aug · Results
  Financial Results for the period ended June 30, 2015. (opens in a new tab)
- 31 Aug · Results
  Standalone & consolidated financial results for the period ended 30-Jun-2015. (opens in a new tab)
- 26 Aug · Clause 20
  Statement of Appropriation for the year ended March 31, 2015 as per Clause 20 of the Listing Agreement. (opens in a new tab)
- 24 Aug · Dividend
  Final Dividend, if declared by the members at the Annual General Meeting to be held on September 29, 2015 will be paid on or after September 30, 2015.
- 24 Aug · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from September 12, 2015 to September 29, ....
- 24 Aug · Results
  Consolidated financial results for the period ended 31-Mar-2015. (opens in a new tab)
- 24 Aug · Results
  Standalone financial results for the period ended 31-Mar-2015. (opens in a new tab)
- 24 Aug · Meeting
  Register of Members and Share Transfer Books of the Company shall remain closed from September 12, 2015 to September 29, 2015 (both days inclusive) for the purpose of Final dividend & Annual General Meeting of the Company scheduled to be held on September 29, 2015. (opens in a new tab)
- 24 Aug · Board meeting
  Outcome of Board Meeting held on August 22, 2015. (opens in a new tab)
- 24 Aug · Dividend
  Board of Directors of the Company at their meeting held on August 22, 2015 has recommended the Final dividend @100% (i.e. Rs. 2.00 per equity share of Rs. 2.00 each) on the paid-up equity share capital of the Company. (opens in a new tab)
- 24 Aug · Board meeting
  Inter alia, to consider and take on record the Unaudited Financial Results (Provisional) of the Company for the quarter ended June 30, 2015. (opens in a new tab)
- 22 Aug · Results
  Financial Results for the period ended March 31, 2015. (opens in a new tab)